HIGHLIGHTS
- who: Stefan Ilic and colleagues from the Department of Chemistry, Ben-Gurion University of the Negev, Beer-Sheva, Israel have published the paper: DnaG Primase-A Target for the Development of Novel Antibacterial Agents, in the Journal: (JOURNAL)
- what: The authors provide an overview of the current literature on DNA primases as novel drug targets and the methods used to find their inhibitors.
SUMMARY
Even though bacteria possesses approximately 200 essential gene products, only a limited number of these have been exploited as drug_targets. Within a replisome of every living cell . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.